Family Medicine · San Jose, CA
NPI
1760485171
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3640 Sweigert Rd
San Jose, CA, 95132
Phone (408) 318-2840
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$159K
3,010 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Vincent Le prescribed most often to Medicare patients was Levetiracetam, with 162 prescriptions and refills. In total Vincent Le wrote 3,010 Medicare prescriptions that cost $159K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levetiracetam Generic | 162 | 165 | 16 | $11K |
| Levothyroxine Sodium Generic | 151 | 152 | 13 | $1,825 |
| Lacosamide Generic | 121 | 123 | Under 11 | $16K |
| Atorvastatin Calcium Generic | 119 | 124 | Under 11 | $1,542 |
| Diazepam Generic | 110 | 111 | 12 | $1,852 |
| Metoprolol Tartrate Generic | 95 | 108 | Under 11 | $663 |
| Famotidine Generic | 84 | 86 | Under 11 | $1,163 |
| Hydrochlorothiazide Generic | 78 | 81 | Under 11 | $240 |
| Glycopyrrolate Generic | 74 | 74 | Under 11 | $2,891 |
| Sodium Chloride Sodium Chloride Irrig Solution | 72 | 72 | Under 11 | $3,829 |
| Lorazepam Generic | 71 | 71 | 22 | $375 |
| Amlodipine Besylate Generic | 68 | 71 | Under 11 | $571 |
| Omeprazole Generic | 67 | 68 | Under 11 | $1,126 |
| Clonazepam Generic | 62 | 63 | Under 11 | $707 |
| Pantoprazole Sodium Generic | 58 | 68 | Under 11 | $6,725 |
Brand drugs: 222 claims; generic drugs: 2,722 claims; opioid claims: 30.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Vincent Le were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.